# Emmessar Biotech & Nutrition Ltd (EMMESSA)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹25.65
Day Change: -4.93%
52W High: ₹42.9
52W Low: ₹18.42
Market Cap: ₹13 Cr

## Valuation
P/E: 40.08
P/B: 10.81
EPS: ₹0.64
Book Value: ₹2.37
Dividend Yield: 0%

## Returns
1Y Return: -24.54%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Emmessar Biotech & Nutrition Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Emmessar Biotech & Nutrition Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Newspaper Add On Relodgement Of Shares
- Quarterly Report: Newspaper Add For Financial Results For The Period Ended March 31, 2026
- BSE Filing: Newspaper Add On Relodgement Of Shares

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-17T00:00:11.492Z
Price History Updated: 2026-05-19T01:03:00.740Z
Latest Price History Date: 2026-05-15
Technicals Updated: 2026-05-19T01:03:00.740Z
Quant Updated: 2026-05-19T01:03:00.740Z
Sentiment Updated: 2026-05-19T01:03:00.740Z
Financials Status: current
Financials Updated: 2026-05-18T15:30:00.976Z
Financials Last Attempt: 2026-05-18T15:30:00.976Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (FY 2023)
Revenue: ₹1 Cr
Operating Profit: ₹-1 Cr (OPM -74.89%)
Net Profit: ₹1 Cr
Tax: ₹0 Cr

## Annual P&L History
FY 2023: Rev ₹1Cr | PAT ₹1Cr | OPM -74.89%
FY 2024: Rev ₹1Cr | PAT ₹1Cr | OPM -211.85%

## Balance Sheet (FY 2022)
Total Assets: ₹7 Cr
Total Liabilities: ₹1 Cr
Borrowings: ₹0 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/emmessa
Disclaimer: For research and education only. Not investment advice.